Press "Enter" to skip to content

Posts published in “Guest Content”

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study


This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn, John Connolly, Michael A Fischer, Aaron S Kesselheim, and Joshua J Gagne in BMJ 2018; 361 under…

Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets


This article was originally published by Antti Jekunen in Drug Des Devel Ther. 2014; 8: 2009–2016 under a Creative Commons Attribution – Non Commercial (unported, v3.0) License. Abstract Decision-making is a core function…

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry
✓ 505(b)(2) & Biosimilars
✓ Insightful Articles & Case Studies
✓ Patent Litigation & Challenges

First 30 days free

➤ Sign up
Do NOT follow this link or you will be banned from the site!